BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 15147815)

  • 1. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.
    Gorbet MB; Sefton MV
    Biomaterials; 2004 Nov; 25(26):5681-703. PubMed ID: 15147815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboinflammation in Therapeutic Medicine.
    Ekdahl KN; Teramura Y; Asif S; Jonsson N; Magnusson PU; Nilsson B
    Adv Exp Med Biol; 2015; 865():3-17. PubMed ID: 26306440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in biomaterial-induced inflammation.
    Nilsson B; Ekdahl KN; Mollnes TE; Lambris JD
    Mol Immunol; 2007 Jan; 44(1-3):82-94. PubMed ID: 16905192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI).
    Brockman KS; Kizhakkedathu JN; Santerre JP
    Acta Biomater; 2017 Jan; 48():368-377. PubMed ID: 27818307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation on biomaterials requires the combination of distinct activation processes.
    Sperling C; Fischer M; Maitz MF; Werner C
    Biomaterials; 2009 Sep; 30(27):4447-56. PubMed ID: 19535136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of surface characteristics of materials to trigger leukocyte tissue factor expression.
    Fischer M; Sperling C; Tengvall P; Werner C
    Biomaterials; 2010 Mar; 31(9):2498-507. PubMed ID: 20035991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
    Leong HS; Mahesh BM; Day JR; Smith JD; McCormack AD; Ghimire G; Podor TJ; Rose ML
    J Leukoc Biol; 2008 Feb; 83(2):263-71. PubMed ID: 17974709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-leukocyte interactions in thrombosis.
    Cerletti C; Tamburrelli C; Izzi B; Gianfagna F; de Gaetano G
    Thromb Res; 2012 Mar; 129(3):263-6. PubMed ID: 22075180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, complement, and contact activation: partners in inflammation and thrombosis.
    Hamad OA; Bäck J; Nilsson PH; Nilsson B; Ekdahl KN
    Adv Exp Med Biol; 2012; 946():185-205. PubMed ID: 21948369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
    Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
    Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.
    Strohbach A; Busch R
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant.
    Sokolov A; Hellerud BC; Tønnessen TI; Johannessen EA; Mollnes TE
    J Biomed Mater Res A; 2013 Feb; 101(2):575-81. PubMed ID: 22949225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review. Endotoxins and blood coagulation].
    Kase F; Rennerová J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):1-15. PubMed ID: 6164602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemocompatibility testing of biomaterials using human platelets.
    Jung F; Braune S; Lendlein A
    Clin Hemorheol Microcirc; 2013; 53(1-2):97-115. PubMed ID: 22954639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers influence the hemostatic system by activating the intrinsic coagulation pathway in an in vitro Chandler-Loop model.
    Paul A; Avci-Adali M; Neumann B; Guo K; Straub A; Dietz K; Ziemer G; Wendel HP
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):161-9. PubMed ID: 19117958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
    Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
    Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation and thrombosis in xenotransplantation between pigs and humans.
    Zhang B; Zhang A; Zhao Y
    Thromb Res; 2008; 121(4):433-41. PubMed ID: 17644165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial thrombosis for the interventional cardiologist: from adhesion molecules and coagulation factors to clinical therapeutics.
    Conde ID; Kleiman NS
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):236-46. PubMed ID: 14517933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood interactions with noble metals: coagulation and immune complement activation.
    Hulander M; Hong J; Andersson M; Gervén F; Ohrlander M; Tengvall P; Elwing H
    ACS Appl Mater Interfaces; 2009 May; 1(5):1053-62. PubMed ID: 20355891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.